Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
286.6 SAR | -0.83% | +3.69% | +0.92% |
Jun. 03 | Dr. Sulaiman Al Habib Medical Services Secures Final License for Hospital Operations in Saudi Arabia | MT |
May. 19 | Dr. Sulaiman Al Habib Medical Services Declares Q1 Dividend | MT |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Strengths
- Analysts expect a sharply increasing business volume for the group, with high growth rates in the coming years.
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
Weaknesses
- With an expected P/E ratio at 45.94 and 37.8 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- Based on current prices, the company has particularly high valuation levels.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- The company is not the most generous with respect to shareholders' compensation.
- For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+0.92% | 26.97B | C+ | ||
+22.65% | 86.96B | C+ | ||
-23.68% | 75.65B | B- | ||
+7.73% | 17.89B | A- | ||
-13.47% | 16.58B | B | ||
+2.68% | 15.73B | A- | ||
+69.13% | 13.01B | C- | ||
+74.99% | 12.92B | C+ | ||
+4.06% | 12.5B | A- | ||
+21.12% | 12.36B | B- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- 4013 Stock
- Ratings Dr. Sulaiman Al Habib Medical Services Group Company